Now that we have a product/platform, having "eugeni" in the link is better for SEO (search engine optimisation) purposes.
Strategy is changing, this is all about EuGeni as a platform - that can perform multiple tests (the rest are coming). Instead of Anteo's single Covid-19 ART. Selling the idea of buying a platform with a suite of tests creates more value in their mind, ie their initial investment on the reader won't be wasted once Covid-19 is over (if that will ever happen). Value prop will eventually be, "one platform that does all the jobs".
On another note, have emailed the company about TGA in June, it is confirmed that it is a mistake, as MDSAP is taking priority instead.
Ann: Test Platform and COVID-19 Test receive CE Mark approval, page-873
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.73M | |||
| Open | High | Low | Value | Volume |
| 2.6¢ | 2.6¢ | 2.6¢ | $8.452K | 325.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 2867613 | 2.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.6¢ | 467679 | 2 |
View Market Depth
| Last trade - 13.35pm 01/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |